Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM74A1 (family with sequence similarity 74 member A1) is annotated as a putative or predicted gene, but there is no direct evidence that this is a functional protein or lncRNA in humans[7][1][5]. It does not appear in key databases for drug targets, and there are no published studies attributing biological, enzymatic, receptor, transporter, or transcriptional activity to this entity. Unlike the related FAM20A or FAM20C, which are well-studied pseudokinases with established disease roles, FAM74A1 remains a largely uncharacterized gene with no known therapeutic or biomarker applications, and is not currently considered a drug target or a biomolecule of pharmacological interest[7][1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 74 member A1 (FAM74A1).